Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Global Medical Devices/ Equipment Market Major Competitor, Industry Development and Market Overview Analysis Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/05/2019 | 12:36pm EDT

Medtronic Inc Was The Largest Company In The Medical Devices Market, According To TBRC's Report (Companies: Medtronic Inc., Johnson & Johnson, GE Healthcare, Cardinal Health, Inc. And Siemens Healthineers)

The global medical devices market was valued nearly at $384 billion in 2017. North America was the largest market for medical devices, accounting for around 43% of the global market in 2018. The USA is the largest country in terms of value in the medical devices market.

The medical equipment market in this report is segmented into in-vitro diagnostics, cardiovascular devices, diagnostic equipment, orthopedic devices, hospital supplies, ophthalmic devices, nephrology and urology devices, patient monitoring devices, dental equipment and supplies, wound care devices, diabetes care devices, surgical equipment, ENT devices, anesthesia and respiratory devices and neurology devices.

Read More On The Global Medical Devices Market Report At:

https://www.thebusinessresearchcompany.com/report/medical-devices-market

Medical Devices Market Size

The medical devices market is expected to grow at a growth rate of around 5% to nearly $522 billion by 2022.Growth in the medical devices market in the historic period resulted from rapid growth in elderly population, strong economic growth in emerging markets and declining oil prices. Factors that negatively affected growth in the historic period were government regulations and skilled workforces' shortages. Going forward, faster economic growth, advances in technology and busy and sedentary lifestyle risks will drive growth. Rise in interest rates could hinder the growth of this market in the future.

The global medical devices market is fragmented. Players in the market include Medtronic Inc., Johnson & Johnson, GE Healthcare, Cardinal Health, Inc. and Siemens Healthineers.

Medtronic was the largest company in the medical equipment market. Medtronic is a medical technology, services and solutions company and serves hospitals, physicians, clinicians and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is headquartered in Dublin, Ireland.

Request A Free Sample Of The Global Medical Devices Market Report At:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2354&type=smp

The medical devices market is segmented by type of product

By Type of Product- The Medical Devices market can be segmented by type of product into cardiovascular devices, in-vitro diagnostics, diagnostic imaging equipment, orthopedic devices, ophthalmic devices, hospital supplies, diabetes care devices, patient monitoring devices, nephrology and urology devices, anesthesia and respiratory devices, surgical equipment, wound care devices, dental equipment and supplies, ENT devices and neurology devices.The cardiovascular devices market was the largest segment of the medical devices market in 2018 at around 15%. The patient monitoring devices market is expected to be the fastest-growing segment.

By Geography- The Medical Devices market is segmented into Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa, and China and the USA. Among these regions, North America is the largest market for medical devices, accounting for 42.6% of the global market. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, Asia Pacific and Africa will be the fastest growing regions in this market. These will be followed by the South America and Middle East where the markets.

Place a direct purchase copy of this report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2354

About The Business Research Company

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on Linkedin: https://in.linkedin.com/company/the-business-research-company

Media Contact

Company Name: The Business Research Company

Contact Person: Nitin

Email: marketing@tbrc.info

Phone: 08897263534

Address:1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills

City: Hyderabad 500033

State: Telengana

Country: India

Website: https://www.thebusinessresearchcompany.com/report/medical-devices-market

Source: www.abnewswire.com

.

(C) 2019 M2 COMMUNICATIONS, source M2 PressWIRE

Stocks mentioned in the article
ChangeLast1st jan.
CARDINAL HEALTH 0.44% 43.76 Delayed Quote.-1.88%
JOHNSON & JOHNSON -0.20% 131.27 Delayed Quote.1.72%
SIEMENS AG 0.00%End-of-day quote.0.00%
SIEMENS HEALTHINEERS -2.84% 35.625 Delayed Quote.-2.52%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
05:03pJOHNSON & JOHNSON : Now Accepting Global Applications for 2020 Women in STEM2D S..
PU
08/21JOHNSON & JOHNSON : Trump signs student debt forgiveness for disabled veterans
AQ
08/21JOHNSON & JOHNSON : Oklahoma judge expected to rule Monday in opioid case
AQ
08/19JOHNSON & JOHNSON : Congo to use second vaccine to fight Ebola
AQ
08/16JOHNSON & JOHNSON INVESTIGATION UPDA : Kahn Swick & Foti, LLC Continues to Inves..
BU
08/16JOHNSON & JOHNSON : Ebola Crisis-The Vaccines Debate
AQ
08/15JOHNSON & JOHNSON : Janssen Announces European Commission Approval of Imbruvica ..
AQ
08/13JOHNSON & JOHNSON : J&J's Janssen Gets EC OK for Expanded Use of Imbruvica
DJ
08/12JOHNSON & JOHNSON : Thinking about trading options or stock in AbbVie, Bristol-M..
PR
08/12JOHNSON & JOHNSON : Janssen Announces U.S. FDA Accelerated Approval for SIRTURO ..
AQ
More news
Financials (USD)
Sales 2019 81 594 M
EBIT 2019 25 389 M
Net income 2019 18 319 M
Debt 2019 5 892 M
Yield 2019 2,86%
P/E ratio 2019 19,5x
P/E ratio 2020 17,3x
EV / Sales2019 4,32x
EV / Sales2020 4,06x
Capitalization 346 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 148,50  $
Last Close Price 131,27  $
Spread / Highest target 28,7%
Spread / Average Target 13,1%
Spread / Lowest Target -5,54%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Charles O. Prince Independent Director
William David Perez Independent Director
Anne M. Mulcahy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON1.72%347 129
ROCHE HOLDING LTD.12.16%238 668
MERCK AND COMPANY13.74%222 522
NOVARTIS17.97%206 833
PFIZER-20.71%192 868
NOVO NORDISK AS15.68%123 385